Medical Equipment

Global Intravenous (IV) Compounding Automation Market Expected to Reach $3.79 Billion by 2030 at 11.6% CAGR

April 9, 2026April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Intravenous (IV) Compounding Automation Market By 2030 Starting From Its 2026 Size?

The market for intravenous (IV) compounding automation has experienced rapid expansion in recent years. This sector is projected to expand from $2.19 billion in 2025 to reach $2.45 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 11.9%. Historically, this growth has been driven by several factors, including the increased adoption of robotic compounding systems, a rising demand for chemotherapy automation, a heightened emphasis on medication safety, the broadening application of automation in hospitals and pharmacies, and an increased understanding of the importance of workflow efficiency.

The market for automated intravenous (IV) compounding is projected to experience substantial expansion over the coming years. This market is forecast to reach $3.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.6%. During the forecast period, this expansion is primarily driven by factors such as increased funding for AI-powered compounding solutions, wider adoption of automated IV workstations, enhanced software integration with hospital information systems, the spread of remote monitoring and predictive maintenance capabilities, and the creation of more modular and customizable compounding systems. Key trends anticipated during this period encompass breakthroughs in AI and machine learning applied to compounding, progress in robotic and automated devices, the evolution of smart pump and monitoring technologies, novel developments in sterile compounding isolators and safety cabinets, and improvements in compact, space-efficient automation solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30629&type=smp

What Underlying Factors Are Accelerating The Growth Of The Intravenous (IV) Compounding Automation Market?

The increasing need for pharmaceutical products is projected to fuel the expansion of the intravenous (IV) compounding automation market moving forward. A pharmaceutical product refers to a substance or combination of substances developed for the purpose of diagnosing, treating, preventing, or relieving diseases and medical conditions in humans or animals. IV compounding automation plays a crucial role in supporting pharmaceutical products by allowing for the precise, safe, and efficient preparation of complex intravenous medications, thus ensuring accurate dosing, mitigating contamination risks, and enabling healthcare providers to fulfill the rising demand for high-quality therapies. For instance, in November 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association, the total pharmaceutical production in Europe accounted for €390,000 million ($422,803 million) in 2023, up from €363,300 million ($393,857 million) in 2022. This demonstrates that the escalating demand for pharmaceutical products is a significant driver for the growth of the intravenous (IV) compounding automation market.

Which Segment Categories Define The Intravenous (IV) Compounding Automation Market?

The intravenous (iv) compounding automation market covered in this report is segmented –

1) By Product Type: Robotic Compounding Systems, Automated Compounding Devices, Software Solutions, Other Product Types

2) By Service: Installation, Maintenance, Training, Consulting, Support, System Integration, Validation, Software Updates, Calibration, Remote Monitoring

3) By Application: Chemotherapy, Parenteral Nutrition, Antibiotics, Other Applications

4) By End-User: Hospitals, Compounding Pharmacies, Oncology Centers, Other End-Users

Subsegments:

1) By Robotic Compounding Systems: Robotic Arm Based Systems, Closed System Robotic Compounding Units, Hazardous Drug Handling Robots, Sterile Preparation Robotic Platforms

2) By Automated Compounding Devices: Volumetric Compounding Devices, Gravimetric Compounding Devices, Multi Chamber Compounding Units, Automated Parenteral Nutrition Compounding Devices

3) By Software Solutions: Compounding Workflow Management Software, Dose Verification Software, Barcode Based Medication Safety Software, Compounding Data Analytics And Reporting Software

4) By Other Product Types: Semi Automated Compounding Systems, Isolator Based Compounding Systems, Sterile Admixture Preparation Cabinets, Hybrid Compounding Assistance Devices

Which Companies Are Leading Innovation In The Intravenous (IV) Compounding Automation Market?

Major companies operating in the intravenous (iv) compounding automation market are Becton Dickinson and Company, Baxter International Inc., Grifols S.A., ICU Medical Inc., Omnicell Inc., Fresenius Kabi AG, Equashield Medical Ltd., Health Robotics S.r.l., Loccioni Group, Loccioni Group, OPTIMA pharma GmbH, Medimix Systems AG, ARxIUM Inc., General Healthy Co. Ltd., PharmaScope Onco Automation B.V., Comecer SpA, Syntegon Technology GmbH, Parata Pharmacy Automation, B. Braun SE, Aesynt Incorporated, Shenzhen Broadcare Robots Co. Ltd.

Read the full intravenous (iv) compounding automation market report here:

https://www.thebusinessresearchcompany.com/report/intravenous-iv-compounding-automation-market-report

Which Region Currently Holds The Largest Share Of The Intravenous (IV) Compounding Automation Market?

North America was the largest region in the intravenous (IV) compounding automation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) compounding automation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Intravenous (IV) Compounding Automation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30629&type=smp

Browse Through More Reports Similar to the Global Intravenous (IV) Compounding Automation Market 2026, By The Business Research Company

Automated Compounding Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

Intravenous Solutions Market Report 2026

https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

lab automation in drug discovery global market report

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795